Saltar al contenido
Merck
Todas las fotos(1)

Key Documents

View All Documentation

L4283

Sigma-Aldrich

Lithium carbonate

BioXtra, ~99%

Sinónimos:

Carbolithium, Carbonic acid lithium salt

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula lineal:
Li2CO3
Número de CAS:
554-13-2
Peso molecular:
73.89
Beilstein/REAXYS Number:
3999191
EC Number:
209-062-5
MDL number:
MFCD00011084
UNSPSC Code:
12352300
PubChem Substance ID:
24896367

product line

BioXtra

assay

~99%

impurities

≤0.01% Phosphorus (P)
≤0.1% Insoluble matter

mp

618 °C (lit.)

anion traces

chloride (Cl-): ≤0.005%
sulfate (SO42-): ≤0.005%

cation traces

Al: ≤0.0005%
Ca: ≤0.002%
Cu: ≤0.0005%
Fe: ≤0.003%
K: ≤0.01%
Mg: ≤0.01%
NH4+: ≤0.05%
Na: ≤0.05%
Pb: ≤0.001%
Zn: ≤0.0005%

SMILES string

[Li+].[Li+].[O-]C([O-])=O

InChI

1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2

InChI key

XGZVUEUWXADBQD-UHFFFAOYSA-L

¿Está buscando productos similares? Visita Guía de comparación de productos

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H302,H319

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

K E Morrison et al.
The Lancet. Neurology, 12(4), 339-345 (2013-03-05)
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in
N Alessi et al.
Journal of the American Academy of Child and Adolescent Psychiatry, 33(3), 291-304 (1994-03-01)
The use of lithium to treat child and adolescent psychiatric disorders is becoming more common. Since the publication of the report of The Committee on Biological Aspects of Child Psychiatry of the American Academy of Child Psychiatry in 1978, a
Andrea Contestabile et al.
The Journal of clinical investigation, 123(1), 348-361 (2012-12-04)
Down syndrome (DS) patients exhibit abnormalities of hippocampal-dependent explicit memory, a feature that is replicated in relevant mouse models of the disease. Adult hippocampal neurogenesis, which is impaired in DS and other neuropsychiatric diseases, plays a key role in hippocampal
Tom Bschor et al.
Journal of clinical psychopharmacology, 33(1), 38-44 (2013-01-02)
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepressants.The objective was to conduct the first comparison of a lithium
Andrew A Nierenberg et al.
The American journal of psychiatry, 170(1), 102-110 (2013-01-05)
Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectiveness of more tolerable dosages of lithium as part of optimized personalized treatment (OPT).
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico